The article you requested is
Long-Acting Injectable Risperidone and Hospital Readmission: A Mirror-Image Study Using a National Claim-Based Database in Taiwan.
J Clin Psychiatry 2009;70(1):141 [letter]
Copyright 2009 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
- Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: Poor compliance with antipsychotic medication, which
would potentially lead to disease relapse, has been challenging
for psychiatrists when treating schizophrenia. Long-acting
injection of antipsychotics is an appropriate alternative, since
better compliance improves treatment outcomes. Mirror-image
studies, in which each patient acts as his/her own control,
of long-acting injection of conventional antipsychotics have
shown significant decreases in numbers of hospitalizations and
days of hospitalization.